Sun Loo

11PUBLICATIONS

94CO-AUTHORS

Medical virologyMedical microbiology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 04, 2026

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.

|Feb 10, 2026

FLT3-ITD MRD in intensive therapy: footprint, not yet the path.

Sun Loo

|Jul 29, 2025

Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML.

Rithin Nedumannil, Michael Ashby, James Rowland

|Jan 18, 2025

Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

|Sep 24, 2024

How I treat patients with AML using azacitidine and venetoclax.

Andrew H Wei, Sun Loo, Naval Daver

|Sep 24, 2024

Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia.

Sun Loo, Nicola Potter, Adam Ivey

Pageof 2

Frequent Collaborators

10 joint publications

Andrew H Wei

Ing Soo Tiong

Natasha S Anstee

Jad Othman

John Reynolds

Michael Ashby

Chun Yew Fong

Nicola Potter

Stephen B Ting

Richard Dillon

Frequent Collaborators

10 joint publications

Andrew H Wei

7 joint publications

Ing Soo Tiong

6 joint publications

Natasha S Anstee

4 joint publications

Jad Othman